379
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Amlodipine and Loop Diuretics as the Second Anti-Hypertensive Medication for the Treatment of Hypertension with Chronic Kidney Diseases

, , , , , , , , & show all
Pages 210-215 | Received 15 Aug 2010, Accepted 05 Oct 2010, Published online: 24 Jun 2011

REFERENCES

  • Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM; RENAAL Study Group. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study. Arch Intern Med 2003;163(13):1555–1565.
  • Suzuki H, Takenaka T. Recent clinical evidences of RAS inhibitors on chronic kidney diseases. Nippon Jinzo Gakkai Shi 2010;52(2):120–124.
  • Japanese Society of Hypertension. Guidelines for the Management for Hypertension 2009 http://www.jpnsh.org/guideline.html. Last accessed 7 June 2011.
  • Bakris GL, Sarafidis PA, Weir MR, Dahlöf B, Pitt B, Jamerson K, Velazquez EJ, Staikos-Byrne L, Kelly RY, Shi V, Chiang YT, Weber MA for the ACCOMPLISH Trial Investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010;375:1173–1181.
  • Wilson FH, Disse-Nicodème S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science 2001;293(5532):1107–1112.
  • Mimura T, Takenaka T, Kanno Y, Moriwaki K, Okada H, Suzuki H. Vascular compliance is secured under angiotensin inhibition in non-diabetic chronic kidney diseases J Human Hypertens 2008;22(1):38–47.
  • Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 2007;50(6):927–937.
  • Kanno Y, Takenaka T, Nakamura T, Suzuki H. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol 2006;1(4):730–737.
  • Takenaka T, Kojima E, Sueyoshi K, Sato T, Uchida K, Arai J, Hoshi H, Kato N, Takane H, Suzuki H. Seasonal variations of daily changes in blood pressure among hypertensive patients with end-stage renal diseases. Clin Exp Hypertens 2010;32(4):227–233.
  • Takenaka T, Mimura T, Kanno Y, Suzuki H. Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases. Am J Nephrol 2005;25: 417–424.
  • Takenaka T, Sato T, Hoshi H, Kato N, Sueyoshi K, Kobayashi K, Takane H, Kanno Y, Ohno Y, Suzuki H. Zigzagged augmentation index in diabetes. Clin Exp Hypertens 2009;31(8):657–668.
  • Iseki K. Renal outcomes in chronic kidney disease. Nephrology (Carlton) 2010;15(suppl 2):27–30.
  • Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003;108:2154–2169.
  • O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005;46(1):200–204.
  • RD Latham, N Westerhof, P Sipkema, BJ Rubal, P Reuderink, JP Murgo. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures Circulation 1985;72:1257–1269.
  • Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin Nephrol 1992;37(5):235–238.
  • Takenaka T, Takane H, Okada H, Ohno Y, Suzuki H. Long-term effects of calcium antagonists on augmentation index in hypertensive patients with chronic kidney diseases. NDT Plus 2009;2(2):192–193.
  • Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. Self-measured systolic blood pressure in the morning is a strong indicator of decline of renal function in hypertensive patients with non-diabetic chronic renal insufficiency. Clin Exp Hypertens 2002;24:249–260.
  • Takenaka T, Mimura T, Kikuta T, Kato N, Inoue T, Kanno Y, Ohno Y, Kobayashi T, Miyawaki Y, Suzuki H. Time for reflection predicts the progression of renal dysfunction in patients with nondiabetic chronic kidney disease. Clin Exp Hypertens 2009;31(3):220–230
  • Hashimoto J, Hirayama H, Hanasawa T, Watabe D, Asayama K, Metoki H, Kikuya M, Ohkubo T, Totsune K, Imai Y. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home. Clin Exp Hypertens 2005;27(4):331–341.
  • Miyashita H, Aizawa A, Hashimoto J, Hirooka Y, Imai Y, Kawano Y, Kohara K, Sunagawa K, Suzuki H, Tabara Y, Takazawa K, Takenaka T, Yasuda H, Shimada K. Cross-sectional characterization of all classes of antihypertensives in terms of central blood pressure in Japanese hypertensive patients. Am J Hypertens 2010;23(3):260–268.
  • Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286(4):421–426.
  • Covic A, Haydar AA, Bhamra-Ariza P, Gusbeth-Tatomir P, Goldsmith DJ. Aortic pulse wave velocity and arterial wave reflections predict the extent and severity of coronary artery disease in chronic kidney disease patients. J Nephrol 2005;18(4):388–396.
  • Konrad M, Vollmer M, Lemmink HH, van den Heuvel LP, Jeck N, Vargas-Poussou R, Lakings A, Ruf R, Deschênes G, Antignac C, Guay-Woodford L, Knoers NV, Seyberth HW, Feldmann D, Hildebrandt F. Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol 2000;11(8):1449–1459.
  • Takenaka T, Hayashi K, Ikenaga H. Renal microcirculation and blood pressure regulation. Contribution to Nephrology 2004;143:46–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.